Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Good News

Brainstorm Cell Therapeutics Received Written Agreement From FDA, Under Special Protocol Assessment, On Design For Phase 3B Trial Of NurOwn In Amyotrophic Lateral Sclerosis Expected To Start In 2024
Good News
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
5
Translate
Report
5177 Views
Comment
Sign in to post a comment
the stock market is an introvert casino with fewer people on meth.
65Followers
40Following
396Visitors
Follow